US 12,029,797 B2
Fatty acid derivative labeled with positron-emitting radionuclide
Yoshihiro Murakami, Tokyo (JP); Hiroshi Fushiki, Tokyo (JP); and Yuji Fujita, Tokyo (JP)
Assigned to Astellas Pharma Inc., Tokyo (JP)
Appl. No. 17/261,328
Filed by ASTELLAS PHARMA INC., Tokyo (JP)
PCT Filed Jul. 19, 2019, PCT No. PCT/JP2019/028380
§ 371(c)(1), (2) Date Jan. 19, 2021,
PCT Pub. No. WO2020/017620, PCT Pub. Date Jan. 23, 2020.
Claims priority of application No. 2018-136483 (JP), filed on Jul. 20, 2018.
Prior Publication US 2021/0338845 A1, Nov. 4, 2021
Int. Cl. A61K 51/04 (2006.01); C07B 59/00 (2006.01)
CPC A61K 51/0402 (2013.01) [C07B 59/001 (2013.01); C07B 2200/05 (2013.01)] 14 Claims
 
1. A labeled fatty acid derivative represented by formula (I) or a salt thereof,

OG Complex Work Unit Chemistry
(in the formula, any one of R1 to R3 is 18F, the other two are H, and Me is a methyl group).